Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FKBP1A | P62942 | 6/20 | 0.57 |
| ▸ | HPGD | P15428 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | USP2 | O75604 | 2/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.52 |
| ▸ | GPR183 | P32249 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.49 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16468222 | 1.00 | FKBP1A (0.57) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL15543990 | 0.94 | ALDH1A1 (0.62) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL15543992 | 0.94 | ALDH1A1 (0.62) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL15543996 | 0.93 | FKBP1A (0.60) | FKBP1AHPGDALDH1A1SMN1; SMN2GPR183 | |
| SCHEMBL15543994 | 0.93 | FKBP1A (0.60) | FKBP1AHPGDALDH1A1SMN1; SMN2GPR183 | |
| SCHEMBL15560634 | 0.91 | ALDH1A1 (0.60) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL15561014 | 0.91 | FKBP1A (0.60) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL15560633 | 0.91 | ALDH1A1 (0.60) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL15561016 | 0.91 | FKBP1A (0.60) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 | |
| SCHEMBL15542902 | 0.90 | GAA (0.52) | FKBP1AHPGDALDH1A1USP2SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150051144-A1 | COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER DISEASES | CADILA HEALTHCARE LTD (IN) | 2015-02-19 | — | — | US | claimed |
| US-20150051144-A1 | COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER DISEASES | CADILA HEALTHCARE LTD (IN) | 2015-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150051144-A1 | COMPOUNDS FOR THE TREATMENT OF DYSLIPIDEMIA AND OTHER DISEASES | PCSK9, HMGCR, CETP | FKBP1A 1033/4885HPGD 847/4885ALDH1A1 1508/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.